Abu-Hilal M - Search Results

1

Incidence of melanoma and non-melanoma skin cancer in patients with celiac disease: a systematic review and meta-analysis.

Kim PJ, Lansang RP, Ko E, Abu-Hilal M. Kim PJ, et al. Eur J Dermatol. 2023 Oct 1;33(5):506-513. doi: 10.1684/ejd.2023.4565. Eur J Dermatol. 2023. PMID: 38297926

2

Morbidity and Mortality of Melanoma on the Trunk and Extremities Treated With Mohs Surgery Versus Wide Excision: A Systematic Review.

Bednar ED, Zon M, Abu-Hilal M. Bednar ED, et al. Dermatol Surg. 2022 Jan 1;48(1):1-6. doi: 10.1097/DSS.0000000000003250. Dermatol Surg. 2022. PMID: 34608076

3

A systematic review of the risk of cutaneous malignancy associated with ultraviolet nail lamps: what is the price of beauty?

Metko D, Mehta S, Mcmullen E, Bednar ED, Abu-Hilal M. Metko D, et al. Eur J Dermatol. 2024 Feb 1;34(1):26-30. doi: 10.1684/ejd.2024.4616. Eur J Dermatol. 2024. PMID: 38557455

4

Comparison of the Efficacy of Clascoterone, Trifarotene, and Tazarotene for the Treatment of Acne: A Systematic Literature Review and Meta-Analysis.

Shergill M, Ali MU, Abu-Hilal M. Shergill M, et al. Dermatol Ther (Heidelb). 2024 May;14(5):1093-1102. doi: 10.1007/s13555-024-01175-3. Epub 2024 May 11. Dermatol Ther (Heidelb). 2024. PMID: 38733511 Free PMC article. Review.

5

Risk factors for malignancy in adult-onset dermatomyositis.

Bednar ED, Legault K, Pavlova V, Abu-Hilal M. Bednar ED, et al. J Eur Acad Dermatol Venereol. 2024 Jan;38(1):e122-e124. doi: 10.1111/jdv.19478. Epub 2023 Sep 12. J Eur Acad Dermatol Venereol. 2024. PMID: 37641818 No abstract available.

6

Systematic review and network meta-analysis of the risk of Herpes zoster with biological therapies and selective Janus kinase-1 inhibitors in atopic dermatitis.

Manzar D, Nair N, Suntres E, Rodrigues M, Abu-Hilal M. Manzar D, et al. Postepy Dermatol Alergol. 2024 Feb;41(1):72-77. doi: 10.5114/ada.2023.135764. Epub 2024 Feb 28. Postepy Dermatol Alergol. 2024. PMID: 38533363 Free PMC article.

7

Elevation of creatine phosphokinase in moderate-to-severe atopic dermatitis is associated with the use of JAK inhibitors but not dupilumab: A systematic review and meta-analysis.

Manzar D, Suntres E, Nair N, Patel Y, Abu-Hilal M. Manzar D, et al. J Am Acad Dermatol. 2024 Jul;91(1):168-169. doi: 10.1016/j.jaad.2024.03.027. Epub 2024 Mar 28. J Am Acad Dermatol. 2024. PMID: 38554937 Free article. No abstract available.

8

Prevalence of malignancy and associated risk factors in prurigo nodularis patients: a retrospective study.

Savinova I, Alrabai M, Taghaddos D, Abu-Hilal M. Savinova I, et al. Int J Dermatol. 2024 Jun;63(6):e113-e114. doi: 10.1111/ijd.17176. Epub 2024 Apr 11. Int J Dermatol. 2024. PMID: 38602065 No abstract available.

9

Dupilumab and joint-related adverse effects: A systematic review.

Zhou T, Al Muqrin A, Abu-Hilal M. Zhou T, et al. J Eur Acad Dermatol Venereol. 2024 Jul 2. doi: 10.1111/jdv.20221. Online ahead of print. J Eur Acad Dermatol Venereol. 2024. PMID: 38953382 No abstract available.

10

Systematic review and network meta-analysis of the risk of malignancy with biologic therapies and selective Janus kinase-1 inhibitors in atopic dermatitis.

Manzar D, Nair N, Suntres E, Rodrigues M, Alghanemi L, Abu-Hilal M. Manzar D, et al. Postepy Dermatol Alergol. 2024 Jun;41(3):270-275. doi: 10.5114/ada.2024.141125. Epub 2024 Jun 30. Postepy Dermatol Alergol. 2024. PMID: 39027698 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

404 results

Search Page

Filters